Medical Products Fact Sheet
Abbott is an innovative leader in the fast-paced, high-growth medical technology space. Abbott's medical products are advancing disease diagnosis, diabetes management and the treatment of vascular disease and spinal disorders. Abbott had worldwide revenues of $6.3 billion in its Medical Products business in 2007.
Key Businesses/Products
Animal Health
- AlphaTRAK™
Provides veterinarians with fast, convenient and accurate blood glucose results for dogs and cats.
Diabetes Care
- Glucose Monitoring Systems/Test Strips
Abbott's leading-edge glucose monitoring systems and test strips in the United States include FreeStyle Flash®, FreeStyle Freedom™ and Precision Xtra.
Molecular Diagnostics
- PathVysion® HER-2 DNA Probe Kit
A vital tool in the fight against breast cancer, PathVysion detects the HER-2 gene in breast cancer patients.
- UroVysion™ Bladder Cancer Kit
The UroVysion Kit is the first FDA-cleared genomic DNA probe test for monitoring recurrence of bladder cancer.
Spine
- Spine Surgery
Abbott offers devices and implants for the treatment of spinal disorders, traumatic injuries and deformity. Products include PathFinder® and TraXis® for spinal fusion, and the Wallis System for treating disc disease without fusion of the vertebrae (available in Europe).
Vascular
- Coronary
Abbott has a full portfolio of products for cardiovascular disease, including a next-generation drug-eluting stent, Xience™ V (available in Europe and Asia Pacific), and the market-leading metallic stent, Multi-Link Vision®. - Endovascular
Abbott is the only company offering two distinct carotid stents and embolic protection systems – Xact® and Acculink™ – to best meet patient and physician needs in this emerging area of vascular disease. - Vessel Closure
Abbott is a pioneer in developing closure technologies, such as StarClose™, designed to facilitate secure closure of the femoral artery following a catheterization procedure.
